InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Eisele Jeffrey, Vice-Président Exécutif. Insider active across 1 companies, notably Apellis Pharmaceuticals, Inc.. Aggregated, 6 reports have been logged. The latest transaction was filed on 28 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations6 total
€15,025434 shares@ €34.61910.0003% mcap79.9% of flow
Common Stock
SEC:0001127602-22-002814·
€15,025434 shares@ €34.61910.0003% mcap40.0% of flow
Common Stock
SEC:0001127602-22-002814:0·
026,051 shares0
Common Stock
SEC:0001127602-22-002061:0·
026,051 shares0
Common Stock
SEC:0001127602-22-002061·
€3,77189 shares@ €42.36520.0001% mcap20.1% of flow
Common Stock
SEC:0001127602-21-031867·
€3,77189 shares@ €42.36520.0001% mcap10.0% of flow
Common Stock
SEC:0001127602-21-031867:0·
6 of 6 declarations
About Eisele Jeffrey
Jeffrey Eisele is Executive Vice President and Program Team Lead at Apellis Pharmaceuticals, Inc. He oversees product development initiatives and contributes to the company's overall strategy. His experience in the pharmaceutical industry is essential for Apellis's success.
